Efficacy and Safety of Isradipine in Hypertension

Shepherd, Alexander M; Carr, Albert A.; Davidov, Michael; Hamilton, Jennifer H.; Schnaper, H. William; Velasquez, Manuel T.; Brockway, B.; Lm, Prisant; Hamilton, Barbara; Gonasun, Leonard

doi:10.1097/00005344-198904000-00010

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1989

1995

Publication Types

Select...

Article6

Relationship

Self Cite1

Independent5

Authors

Journals

Cited by 21 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[1][2][3][4][5] In those studies, however, blood pressure was measured when ever the patient attended the clinic, and therapy was taken twice daily, once in the morning and again in the evening. Thus, the blood pressure measurements re flected the effects of the drug between its peak period and its trough.…”

Section: Discussionmentioning

confidence: 99%

Isradipine Twice Daily Lowers Blood Pressure Over 24 H

Lasance

et al. 1991

American Journal of Hypertension

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Isradipine Twice Daily Lowers Blood Pressure Over 24 H

Lasance

et al. 1991

American Journal of Hypertension

View full text Add to dashboard Cite

Isradipine vs Propranolol in Hydrochlorothiazide-Treated Hypertensives

Prisant

Carr²,

Nelson³

et al. 1989

Arch Intern Med

View full text Add to dashboard Cite

Evaluation of antihypertensive effects of once‐a‐day isradipine and fosinopril: A double‐blind crossover study by means of ambulatory blood pressure monitoring

Perticone

Pugliese

Marcantonio

et al. 1995

Clinical Cardiology

View full text Add to dashboard Cite

Summary:We compared the efficacy and tolerability of isradipine (ISR) and fosinopril (FOS) once-a-day administration in 17 outpatients, 9 men and 8 women, aged 35-65 years (mean + SD = 58 k 10 years), affected by mild to moderate primary systemic hypertension. The patients were given singleblind placebo for 2 weeks and thereafter, in double-blind, randomized, crossover sequence, ISR (5 mg) and FOS (20 mg), both fur 4 weeks. At the end of each period, patients underwent 24-h noninvasive blood pressure (BP) monitoring by means of an A&D TM 2420 Monitor Model 7, with readings taken every 10 min during the day (from 7 A.M. to 11 P.M.), and every 20 min during the night (from 11 P.M. to 7 A.M. were observed in any patient under either therapy. Both ISR and FOS resulted in very effective decrease in BP; however, FOS proved to be significantly more effective than ISR.

show abstract

Efficacy and Safety of Isradipine in Hypertension

Cited by 21 publications

References 0 publications

Isradipine Twice Daily Lowers Blood Pressure Over 24 H

Isradipine Twice Daily Lowers Blood Pressure Over 24 H

Isradipine vs Propranolol in Hydrochlorothiazide-Treated Hypertensives

Evaluation of antihypertensive effects of once‐a‐day isradipine and fosinopril: A double‐blind crossover study by means of ambulatory blood pressure monitoring

Contact Info

Product

Resources

About